Our latest thinking on biopharmaceutical development and commercialization.

Latest thinking
Immuno-oncology studies are getting increasingly complex, but sponsors can minimize risks by working more collaboratively with CROs and trial sites.

Quintiles Blog

Fresh ideas and insights from our experts around the globe.


Topics to Explore


Advances in genomics and information technology are ushering in a new era for oncology drug development, but biopharmaceutical companies must move the conversation from cost to value.


As the prevalence of diabetes continues to increase globally, and the market for new therapies grows increasingly crowded, it's more important than ever to match the right drug to the right patient.

Data & Technology

To turn data into insights, upgraded IT systems are essential. Outdated systems lead to significant costs – in terms of time, frustration and an increased risk of errors. Integrated IT systems are a crucial component in reducing manual processes, resulting in fewer errors, faster processes, far less frustration and ultimately lowering your costs. Benefit from more insightful data analysis, which can lead to groundbreaking discoveries.

Evidence & Value

Healthcare costs are climbing, regulators around the globe are requiring more information, and both providers and payers have higher expectations for a medical treatment’s proof of value before prescribing or paying for those treatments.

Rare Diseases

Although regulatory incentives and the designation of “orphan” products have stimulated commercial research for rare diseases, their low prevalence, high complexity and predominance in children create significant barriers. Providers and patients are clamoring for treatment access and improved outcomes, but increasingly payers are making hard choices about reimbursing these therapies.


Biosimilar development and commercialization is a uniquely difficult endeavor requiring precise, stepwise planning to ensure timely regulatory approval and optimal market access. 

Peer-Reviewed Publications
Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials.
Stat Med. 2016 Aug 3. doi: 10.1002/sim.7064. [Epub ahead of print]
Read more
Cholesterol-lowering interventions and stroke: Insights from IMPROVE-IT.
Atherosclerosis. 2016 May;248:216-8. doi: 10.1016/j.atherosclerosis.2016.03.024. Epub 2016 Mar 18.
Read more
Overcoming Barriers in Kidney Health-Forging a Platform for Innovation.
J Am Soc Nephrol. 2016 Jul;27(7):1902-10. doi: 10.1681/ASN.2015090976. Epub 2016 Apr 28.
Read more
Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer Tumors.
Mol Cancer Ther. 2016 Jul;15(7):1746-56. doi: 10.1158/1535-7163.MCT-15-0353. Epub 2016 Apr 19.
Read more